Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

76411

registered interest
date	08/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ulipristal Acetate
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that drug retailers accurately describe the operations of their products; if he will require retailers of the drug Ulipristal acetate to detail accurately its abortifacient effects; and if he will make a statement.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	204592
answer	answer is ministerial correction date of answer 14/07/2014 answer text <p>Ulipristal acetate is the active ingredient in the emergency contraceptive known as EllaOne.</p><p> </p><p>Following a High Court ruling in 2002, emergency contraception is defined as a method of contraception not abortion. The decision confirms the Government's long held position that a pregnancy begins at implantation and not fertilisation. This judgment means that this position is now established in law and is not a matter of policy</p><p> </p><p>EllaOne is a contraceptive, it is not an abortifacient.It exerts its contraceptive action by preventing or delaying ovulation.</p><p> </p><p>EllaOne is used to prevent pregnancy for up to five days after unprotected intercourse or contraceptive failure. It is specifically contraindicated for use during an existing or suspected pregnancy</p><p> </p><p>The information provided in each pack of EllaOne clearly informs women and healthcare professionals that it should not be taken by a woman who knows or suspects she is pregnant.</p><p><strong> </strong></p><p><strong> </strong></p><p> </p><p> </p><p> </p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 14/07/2014 14:42:41 answering member 1439 label Biography information for Norman Lamb
tabling member	446 label Biography information for Jim Dobbin

62324

registered interest
date	17/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antidepressants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Answer of 19 January 2012, Official Report, columns 932-3W, how many companies hold licences for the manufacture or distribution of (a) Nitrazepam, (b) Flurazepam, (c) Loprazolam, (d) Lormetazepam, (e) Temazepam, (f) Clonazepam, (g) Medazepam, (h) Midazolam, (i) Zopiclone, (j) Zaleplon, (k) Zolpiden, (l) Eszopiclone, (m) SSRI antidepressants and (n) trycyclic antidepressants; and how many of those licences were issued in the last three years.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	201050
answer	answer is ministerial correction date of answer 23/06/2014 answer text <p>There are currently 15 products authorised in the United Kingdom containing nitrazepam and 15 different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently two products authorised in the UK containing flurazepam and one company authorised to manufacture and distribute them.</p><p> </p><p>There are currently two products authorised in the UK containing loprazolam and two different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently eight products authorised in the UK containing lormetazepam and four different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently 10 products authorised in the UK containing temazepam and six different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently six products authorised in the UK containing clonazepam and three different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently no authorised products in the UK containing medazepam.</p><p> </p><p>There are currently 22 products authorised in the UK containing midazolam and 10 different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently 17 products authorised in the UK containing zopiclone and nine different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently two products authorised in the UK containing zaleplon and one company authorised to manufacture and distribute them.</p><p> </p><p>There are currently 21 products authorised in the UK containing zolpidem and 12 different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently no authorised products in the UK containing eszopiclone.</p><p> </p><p>There are currently 238 products authorised in the UK containing SSRI antidepressants and 57 different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently 16 products authorised in the UK containing tricyclic antidepressants and 11 different companies authorised to manufacture and distribute them.</p><p> </p><p>One loprazolam, four lormetazepam, two clonazepam, two midazolam, three zopiclone, four zolpidem and 75 SSRI products have been authorised in the last three years.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 23/06/2014 15:15:27 answering member 1439 label Biography information for Norman Lamb
tabling member	446 label Biography information for Jim Dobbin

58159

registered interest
date	04/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Terminal Illnesses
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people in England in receipt of free social care are terminally ill.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	199001
answer	answer is ministerial correction date of answer 10/06/2014 answer text <p>Local authorities have a duty to assess the needs of any person for whom the authority may arrange social care and who may be in need of such care. They have a further duty to decide, having regard to the results of the assessment, what, if any, care and support they should provide to meet the individual's needs. Where a local authority decides to arrange care and support it will carry out a financial assessment to decide what an individual can afford to contribute towards the cost. Appeals against decisions by local authorities are considered locally. Information about appeals is not collected centrally.</p><p> </p><p>In its 2011 report, the independent Palliative Care Funding Review recommended the provision of free social care at the end of life. A series of palliative care funding pilots were established to test the review's recommendations, and these completed their work in March 2014. NHS England is currently analysing the financial data collected from the pilots. Once this analysis has been completed, a decision will be made on the issue of free social care at the end of life, taking into account this analysis and wider policy and financial considerations.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 198962 question first answered 10/06/2014 15:21:50 answering member 1439 label Biography information for Norman Lamb
tabling member	446 label Biography information for Jim Dobbin

58160

registered interest
date	04/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Social Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many appeals were made by applicants for social care at the end of their life in the last two years; how many such appeals were successful; and what proportion of total appeals against decisions about social care such appeals represent.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	198962
answer	answer is ministerial correction date of answer 10/06/2014 answer text <p>Local authorities have a duty to assess the needs of any person for whom the authority may arrange social care and who may be in need of such care. They have a further duty to decide, having regard to the results of the assessment, what, if any, care and support they should provide to meet the individual's needs. Where a local authority decides to arrange care and support it will carry out a financial assessment to decide what an individual can afford to contribute towards the cost. Appeals against decisions by local authorities are considered locally. Information about appeals is not collected centrally.</p><p> </p><p>In its 2011 report, the independent Palliative Care Funding Review recommended the provision of free social care at the end of life. A series of palliative care funding pilots were established to test the review's recommendations, and these completed their work in March 2014. NHS England is currently analysing the financial data collected from the pilots. Once this analysis has been completed, a decision will be made on the issue of free social care at the end of life, taking into account this analysis and wider policy and financial considerations.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 199001 question first answered 10/06/2014 15:21:49 answering member 1439 label Biography information for Norman Lamb
tabling member	446 label Biography information for Jim Dobbin

50398

registered interest
date	08/05/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the findings of the recent Global Forum on Incontinence into improving health and social care in incontinence.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	198200
answer	answer is ministerial correction date of answer 13/05/2014 answer text <p>No assessment has been made of the findings of the recent Global Forum on Incontinence (GFI) into improving health and social care in incontinence. However, we applaud the work of the GFI and the work it is doing to improve the health and social care provisions for incontinence, giving patients and care givers a better quality of life.</p><p> </p><p>Responsibility for continence services sit with NHS England and clinical commissioning groups (CCG). CCGs are responsible for commissioning high quality continence services based on an assessment of local need and performance managing their providers in the delivery of high quality services.</p><p> </p><p>The Mandate to NHS England requires it to deliver continued improvements in relation to enhancing the quality of life for people with long-term conditions, including those suffering incontinence, across the five domains of the NHS Outcomes Framework. NHS England will be taking forward a major programme of work through the Primary Care Strategy; it has established a working group on continence care and will provide an update for the All Party Parliamentary Group for Continence Care on 24 June.</p><p> </p><p>To improve standards in continence care, the Department commissioned the National Institute for Health and Care Excellence (NICE) to develop clinical guidelines on the management of urinary incontinence in women (issued in 2006) and faecal incontinence in adults (issued in 2007), which are supported by commissioning tools to support CCGs. In February, NICE published a clinical Quality Standard on Faecal Incontinence, QS54, which describes high-priority areas for quality improvement in this area. NHS England continues to champion the use of Quality Standards with both commissioners and providers.</p><p> </p><p>We believe all patients have the right to be treated with dignity, respect and compassion.</p><p> </p><p>We recognise that continence can impact on every aspect of peoples' lives and that it often requires a joined approach from both health and social care services. That is why in April the Department published the policy paper, <em>Transforming Primary Care: safe proactive, personalised care for those who need it</em>, which focuses on improving and individualising the management of out of hospital care, directly supporting those with continence problems by creating more integrated health and social care services. This paper has been placed in the Library.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 13/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb attachment 1 file name PQ198200 - Library Doc - Report.pdf title Transforming Primary Care
tabling member	446 label Biography information for Jim Dobbin

48568

registered interest
date	25/04/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of potential correlation between relative deprivation and the prescribing rates of benzodiazepines at GP practices.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	196616
answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Department has undertaken no such assessment.</p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
tabling member	446 label Biography information for Jim Dobbin